Hospital

The medication is newly indication for reducing the risk of major adverse cardiovascular events (MACE) including cardiovascular death, nonfatal heart attack, or nonfatal stroke in adults with type 2 diabetes and established cardiovascular disease (CVD).

Megan Maroney, PharmD, BCPP, clinical associate professor, Ernest Mario School of Pharmacy at Rutgers, the State University of New Jersey; clinical psychiatric pharmacist, Monmouth Medical Center, Long Branch, NJ, discusses the higher risk for potential adverse effects of suicidal ideation and behavior, and depression in younger patients.

From newsworthy moments to groundbreaking research, these are the most popular articles published on Pharmacy Times® during 2019.

The applications for the first generics of apixaban (Eliquis, Bristol-Meyers Squibb) tablets were approved to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation

Ubrogepant is the first drug in the class of oral calcitonin gene-related peptide receptor antagonists approved by the agency for the acute treatment of migraine.

Krutika Mediwala, PharmD, BCPS, discusses the effects that institutional policies can have on antimicrobial stewardship in health systems. This video was filmed at the ASHP (American Society of Health-System Pharmacists) 54th Midyear Clinical Meeting & Exhibition in Las Vegas.

Todd Brothers, PharmD, BCCCP, BCPS clinical assistant professor, University of Rhode Island, discusses the role of pharmacists in assessing patients for hyperkalemia and in managing those with a chronic condition. This video was filmed at the ASHP (American Society of Health-System Pharmacists) 54th Clinical Meeting & Exhibition in Las Vegas, Nevada.

There is a statistically significant difference in the number of patients that meet statin criteria for primary prevention, and those that were prescribed it in a Federally Qualified Health Center (FQHC), according to student research presented at the ASHP (American Society of Health-System Pharmacists) 54th Midyear Clinical Meeting & Exhibition in Las Vegas, Nevada.